ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LXEO Lexeo Therapeutics Inc

13.85
-0.17 (-1.21%)
May 17 2024 - Closed
Delayed by 15 minutes

Lexeo Therapeutics Financial Summary

The current LXEO market cap is 369.37M. The company's latest EPS is USD -2.4896 and P/E is -5.55.

Quarter End
USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 1.66M654k0
Operating Income -50.64M-60.51M-68.51M
Net Income -50.62M-59.28M-66.39M
Quarter End
USD ($)USD ($)USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 136.86M97.08M139.81M
Total Liabilities 7.45M25M26.27M
Total Equity -55.6M-112.95M113.54M
Quarter End
USD ($)USD ($)USD ($)
Operating
Investing
Financing
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -44.18M-54.56M-59.5M
Investing -188k-901k-165k
Financing 150.86M189k103.79M
Market Cap 369.37M
Price to Earnings Ratio -5.55
Price to Sales Ratio 0
Price to Cash Ratio 3.03
Price to Book Ratio 3.25
Dividend Yield -

Share Statistics

Shares Outstanding 26.67M
Average Volume (1 week) 128.98k
Average Volume (1 Month) 144.56k
52 Week Change 45.79%
52 Week High 22.33
52 Week Low 9.00
Spread (Intraday) 3.42 (20.83%)

Company Info

Company Name Lexeo Therapeutics Inc
Address
Industry biological pds,ex diagnstics (2836)